Adjunct therapy for type 1 diabetes mellitus

被引：0
|
作者：
Harold E. Lebovitz
机构：
[1] State University of New York Health Science Center at Brooklyn,Department of Medicine, Division of Endocrinology
来源：
Nature Reviews Endocrinology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Insulin replacement therapy in type 1 diabetes mellitus (T1DM) leads to peripheral hyperinsulinemia, which is associated with potentially serious metabolic complications, such as increased hypoglycemia, weight gain and postprandial hyperglucagonemia. This Review discusses adjunctive therapies to minimize these complications in patients with T1DM, with a focus on the islet amyloid polypeptide analog pramlintide.
引用
收藏
页码：326 / 334
页数：8
相关论文
共 50 条
  • [21] Oral tolerance therapy in type 1 diabetes mellitus
    Mao, Rui-Feng
    Chen, Ying-Ying
    Diao, En-Jie
    Chang, Xin
    Chi, Zhen-Jing
    Wang, Ye-Fu
    CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 44 - 46
  • [22] Modern insulin therapy for type 1 diabetes mellitus
    Lorenz, RA
    PRIMARY CARE, 1999, 26 (04): : 917 - +
  • [23] Novel cell therapy for type 1 diabetes mellitus
    Luft, Friedrich C.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (07): : 659 - 661
  • [24] Stem cell therapy for type 1 diabetes mellitus
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (8): : 559 - 560
  • [25] Novel cell therapy for type 1 diabetes mellitus
    Friedrich C. Luft
    Journal of Molecular Medicine, 2009, 87
  • [26] Type 1 diabetes mellitus: Differential diagnosis and therapy
    Jaursch-Hancke, C
    MEDIZINISCHE WELT, 2000, 51 (7-8): : 204 - 207
  • [27] Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?
    Odimegwu, Chioma Laura
    Uwaezuoke, Samuel Nkachukwu
    Chikani, Ugo N.
    Mbanefo, Ngozi Rita
    Adiele, Ken Daberechi
    Nwolisa, Charles Emeka
    Eneh, Chizoma Ihuarula
    Ndiokwelu, Chibuzo Obiora
    Okpala, Somkenechi C.
    Ogbuka, Francis N.
    Odo, Kenneth E.
    Ohuche, Ijeoma Onyinyechukwu
    Obiora-Izuka, Chinelo Elizabeth
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3557 - 3576
  • [28] Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
    Monnier, Louis
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (04): : 332 - 333
  • [29] Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
    Louis Monnier
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 332 - 333
  • [30] Metformin use as an adjunct to insulin treatment in selected patients with type 1 diabetes mellitus
    Gunton, JE
    Twigg, SM
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (11) : 591 - 592
12345